Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: ACS Chem Neurosci. 2020 Dec 15;12(1):234–243. doi: 10.1021/acschemneuro.0c00711

Figure 3–

Figure 3–

Deuterium label loss and kinetic isotope effect for lactate, glutamate and glutamine in rat brain following 20 min of intravenous infusion of [6,6-2H2, 6-13C]-glucose and [5,6-13C2]-glucose. (A) Experimental 13C NMR spectrum (top) for [4-13C]-glutamate together with the fitted contributions from non-deuterated [4-13C]-glutamate (red), single-deuterated [4-2H, 4-13C]-glutamate (blue), double-deuterated [4,4-2H2, 4-13C]-glutamate (green) and non-deuterated [4, 5-13C2]-glutamate (gray). The residual between the experimental and total fitted spectra is shown as the bottom trace. (B) Deuterium label loss for [3-13C]-lactate, [4-13C]-glutamate and [4-13C]-glutamine originating from [6,6-2H2,6-13C]-glucose. Non, single and double-deuterated compounds are indicated by red, blue and green bars, respectively. For each compound the sum of the three contributions equals 100%. (C) Kinetic isotope effect for lactate, glutamate and glutamine. The absolute amounts of non, single and deuterated compounds are added together and compared to the absolute amount of [2,3-13C2]-lactate or [4,5-13C2]-glutamate or glutamine which is defined as 100%.